Through the Rough Waters of Supply Interruptions

Recent shortages of immunoglobulin (Ig) products are impacting the access to care of patients across the US and worldwide. It is likely that your organization and your patients are affected by the limited availability of a specific product. What are some of the...

IVIg in the Treatment of Autoimmune Blistering Diseases

Intravenous immunoglobulin (IVIg) has been shown to be effective in the treatment for autoimmune blistering diseases like pemphigus vulgaris and bullous pemphigoid. While the precise mechanism of action is unknown, high-dose IVIg can be effective in achieving and...

The Intersection of Immune Deficiency and Autoimmunity

The connection between immune deficiency and autoimmunity is well recognized. This tangled web presents a wide variety of clinical presentations and outcomes. Advances in understanding of the molecular and cellular biology of these diseases have led to improvements in...

Solid Organ Transplantation

Ig therapy plays an important immunomodulatory role in incompatible organ transplantation with proven benefit for the desensitization of highly sensitized patients pretransplant to improve transplant rates and clinical outcomes. As the use of Ig therapy expands in...

Building a Culture of Safety: No Heroes Allowed

This program addresses the history and current state of preventable medical harm in the U.S. and the impact teamwork deficiencies on patient outcomes. The audience will be drawn into a conversation on the impact of our hierarchical structure on patient care. This...